A Study of Tadalafil in Men With Benign Prostatic Hyperplasia Symptoms Who Are Being Treated With Alpha Blockers

Clinical trial NCT00848081 · COMPLETED

Trial details

NCT number: NCT00848081
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Benign Prostatic Hyperplasia

Start date: 2009-03-01
Primary completion: 2009-12-01
Enrollment: 318

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.